Clinical Study

The Clinical Efficacy and Safety of Ertapenem for the Treatment of Complicated Urinary Tract Infections Caused by ESBL-Producing Bacteria in Children

Table 3

Resistance rates of Enterobacteriaceae strains against antimicrobial agents, (%).

Ampicillin75 (97.4)
Ceftriaxone75 (97.4)
Trimethoprim-sulfamethoxazole46 (59.7)
Piperacillin-tazobactam42 (54.5)
Gentamicin23 (29.9)
Nitrofurantoin16 (20.8)
Carbapenems (ertapenem, meropenem, and imipenem)ā€”